Zynex Stock

Zynex Gross Margin

Delisted·Dec 23, 2025

The Gross Margin of Zynex (ZYXI) as of Aug 25, 2026 is 79.50 %. In the previous year, Gross Margin was 79.19 % — a change of 0.40% (higher).

Gross Margin

79.50 %

YoY

0.40%

Last updated:

Gross Margin of Zynex is 2026 79.50 % . Gross Margin of Zynex was 2025 79.19 % . It decreases by 0.40% higher compared to the previous year.

For Zynex, the gross margin of 79.5% is up versus 78.3% a few years ago.

The Zynex Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2017
79.43 USD
Jan 1, 2018
81.08 USD
Jan 1, 2019
80.62 USD
Jan 1, 2020
78.26 USD
Jan 1, 2021
79.03 USD
Jan 1, 2022
79.77 USD
Jan 1, 2023
79.19 USD
Jan 1, 2024
79.50 USD
The Zynex Gross Margin history
YEARGross MarginYoY
79.50 %+0.40%
79.19 %-0.73%
79.77 %+0.93%
79.03 %+0.98%
78.26 %-2.92%
80.62 %-0.57%
81.08 %+2.07%
79.43 %+7.95%
73.58 %+27.77%
57.59 %+82.66%
31.53 %+4,947.69%
0.62 %-19.81%
0.78 %-0.67%
0.78 %+0.02%
0.78 %-1.62%
0.80 %-1.56%
0.81 %-10.97%
0.91 %+3.20%
0.88 %+2.12%
0.86 %
Access this data via the Eulerpool API

Zynex Stock analysis

What does Zynex do? Zynex Inc is an American company that manufactures and distributes medical devices and accessories. The company was founded in 1996 and is headquartered in Englewood, Colorado. In recent years, it has become a major player in the pain therapy market. The history of Zynex began with the development of a neurotherapeutic system called NeuroMove, which aimed to restore mobility in patients with paralysis after strokes or other neurological disorders. The company uses proprietary technology to provide safe and effective electrotherapeutic stimulation, which helps trigger muscle contractions and improve mobility. Over the years, the company has specialized in the development and sale of medical devices for pain therapy and rehabilitation. Zynex's products can be used in various areas, including electrostimulation, TENS and EMS therapy, home diagnostics, as well as blood pressure and oxygen measurement. Zynex offers devices specifically for pain therapy. These devices are used by many doctors and physiotherapists to support patients in their healing process. The company's flagship product is the Nexus D-11 EMS and TENS device, which is capable of conducting multiple pain treatments simultaneously. Another important device from Zynex is the InWave system, which applies FDA-approved electromagnetic wave therapy. The therapy is used for both acute and chronic pain and aims to promote the body's natural healing processes to relieve pain. Zynex also manufactures home diagnostic devices such as the blood sugar monitor and pulse oximeter, which can be regularly used by patients at home to monitor their well-being. These products help individuals develop an understanding of how their body responds to different treatments or environmental conditions. An important aspect of Zynex's business model is collaborating with healthcare customers. The company forms partnerships with medical facilities and practitioners to ensure that its products are effectively and safely utilized. These partnerships often include training programs to ensure that users of each device develop a basic understanding of how it works to ensure quality treatment. Zynex has also established a subsidiary called Zynex Medical Europe, which operates in European regions. The company is based in the Netherlands and is responsible for marketing and distributing Zynex's products in Europe. Overall, Zynex has established itself as a key player in the field of pain therapy and rehabilitation. Through its innovative technology and healthcare partnerships, the company is able to provide the best possible patient care. Zynex is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zynex stock

Gross Margin of Zynex is 79.50 % in 2026.

Gross Margin of Zynex changed from 79.19 % to 79.50 %, representing a 0.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Zynex since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Zynex with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

Margins — Zynex

All Key Metrics — Zynex